⌘K

Login Start Free

Home/Filings/4/0001628280-21-012172

4//SEC Filing

Erlander Mark 4

Accession 0001628280-21-012172

CIK 0001213037other

View on SEC.gov Company Profile

Filed

Jun 13, 8:00 PM ET

Accepted

Jun 14, 4:11 PM ET

Size

5.5 KB

Accession

0001628280-21-012172

Insider Transaction Report

Form 4

Period: 2021-06-10

Cardiff Oncology, Inc.CRDF

DirectorChief Executive Officer

Transactions

Award
Stock Options
2021-06-10+435,072→ 815,272 total
Exercise: $7.98Exp: 2031-06-10→ Common Stock (435,072 underlying)

Footnotes (1)

[F1]108,768 vest on 6/10/2022. 9,064 vest monthly for 36 months beginning on 7/10/2022 through 6/10/2025.

Documents

1 file

4
wf-form4_162370149350115.xmlPrimary
FORM 4

Issuer

Cardiff Oncology, Inc.

CIK 0001213037

Entity typeother

Related Parties

1

filerCIK 0001651537

Filing Metadata

Form type: 4
Filed: Jun 13, 8:00 PM ET
Accepted: Jun 14, 4:11 PM ET
Size: 5.5 KB

View on SEC.gov